← Back
$KYMR All transactions

Kymera Therapeutics, Inc.

A

$ Value

$0

Shares

16,000

Price

$0

Filed

Jun 26

Insider

Name

Hrustanovic Gorjan

Title

CIK

0001821194

Roles

Director

Transaction Details

Transaction Date

2025-06-25

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

16,000

Footnotes

The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 25, 2026 and (ii) the date of the next annual meeting of the Issuer's stockholders. | The Reporting Person is a member of BVF Partners L.P. ("BVF") and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the equity grants to BVF. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.

Filing Info

Accession No.

0000950170-25-090584

Form Type

4

Issuer CIK

0001815442

Hrustanovic Gorjan's History

Date Ticker Type Value
2025-06-25 KYMR A $0
2025-06-11 OLMA A $0

Other Insiders at KYMR (90d)

Insider Bought Sold Last
Chadwick Jeremy G
Chief Operating Officer
$11.5M 2026-04-15
Booth Bruce $855K 2026-04-15
Ridloff Elena $1.0M 2026-04-01
Goodman Noah
Chief Business Officer
$1.0M 2026-04-14